News
Bavarian Nordic receives European approval of vaccine label Imvanex
Bavarian Nordic has announced that the European Commission (EC) has extended the marketing authorization for the company’s smallpox vaccine, Imvanex. The treatment will also include protection from monkeypox and disease caused by vaccinia virus.